Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Toyo Aerosol Industry Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This application is under the review of PACKARD, BENJAMIN J, who is the busiest examiner for the portfolio with 1 pending office action. The entire pending workload is concentrated within 1 distinct examiner and 1 distinct art unit, allowing for a streamlined and focused prosecution strategy.
Having only 1 pending office action means that the company's current interactions with the patent office are limited to a single official. This concentration under PACKARD, BENJAMIN J simplifies the management of the application, as the company only needs to address the specific concerns of 1 distinct examiner. However, the reliance on 1 distinct art unit within the Biotechnology & Pharmaceuticals sector means that the company's progress is subject to the specific technical standards and interpretive trends of that single department. This singular focus requires a deep understanding of the examiner's previous decisions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PACKARD, BENJAMIN J | 1 | 66.9% | +15.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18969825 | ANTIVIRAL AEROSOL COMPOSITION, COATING FILM, AND ARTICLE | PACKARD, BENJAMIN J | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18969825 | ANTIVIRAL AEROSOL COMPOSITION, COATING FILM, AND ARTICLE | PACKARD, BENJAMIN J | 1612 | §103DP | Non-Final OA | — | Pending | Dec 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialToyo Aerosol Industry Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Benjamin J Packard has the most, with 1 of Toyo Aerosol Industry Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
